Loss of miR-29a/b1 promotes inflammation and fibrosis in acute pancreatitis

MicroRNA-29 (miR-29) is a critical regulator of fibroinflammatory processes in human diseases. In this study, we found a decrease in miR-29a in experimental and human chronic pancreatitis, leading us to investigate the regulatory role of the miR-29a/b1 cluster in acute pancreatitis (AP) utilizing a...

Full description

Bibliographic Details
Main Authors: Shatovisha Dey, Lata M. Udari, Primavera RiveraHernandez, Jason J. Kwon, Brandon Willis, Jeffrey J. Easler, Evan L. Fogel, Stephen Pandol, Janaiah Kota
Format: Article
Language:English
Published: American Society for Clinical investigation 2021-10-01
Series:JCI Insight
Subjects:
Online Access:https://doi.org/10.1172/jci.insight.149539
_version_ 1811329179695710208
author Shatovisha Dey
Lata M. Udari
Primavera RiveraHernandez
Jason J. Kwon
Brandon Willis
Jeffrey J. Easler
Evan L. Fogel
Stephen Pandol
Janaiah Kota
author_facet Shatovisha Dey
Lata M. Udari
Primavera RiveraHernandez
Jason J. Kwon
Brandon Willis
Jeffrey J. Easler
Evan L. Fogel
Stephen Pandol
Janaiah Kota
author_sort Shatovisha Dey
collection DOAJ
description MicroRNA-29 (miR-29) is a critical regulator of fibroinflammatory processes in human diseases. In this study, we found a decrease in miR-29a in experimental and human chronic pancreatitis, leading us to investigate the regulatory role of the miR-29a/b1 cluster in acute pancreatitis (AP) utilizing a conditional miR-29a/b1–KO mouse model. miR-29a/b1-sufficient (WT) and -deficient (KO) mice were administered supramaximal caerulein to induce AP and characterized at different time points, utilizing an array of IHC and biochemical analyses for AP parameters. In caerulein-induced WT mice, miR-29a remained dramatically downregulated at injury. Despite high-inflammatory milieu, fibrosis, and parenchymal disarray in the WT mice during early AP, the pancreata fully restored during recovery. miR-29a/b1–KO mice showed significantly greater inflammation, lymphocyte infiltration, macrophage polarization, and ECM deposition, continuing until late recovery with persistent parenchymal disorganization. The increased pancreatic fibrosis was accompanied by enhanced TGFβ1 coupled with persistent αSMA+ PSC activation. Additionally, these mice exhibited higher circulating IL-6 and inflammation in lung parenchyma. Together, this collection of studies indicates that depletion of miR-29a/b1 cluster impacts the fibroinflammatory mechanisms of AP, resulting in (a) aggravated pathogenesis and (b) delayed recovery from the disease, suggesting a protective role of the molecule against AP.
first_indexed 2024-04-13T15:39:14Z
format Article
id doaj.art-ccd29945ae6d4cd399638e7be17fca29
institution Directory Open Access Journal
issn 2379-3708
language English
last_indexed 2024-04-13T15:39:14Z
publishDate 2021-10-01
publisher American Society for Clinical investigation
record_format Article
series JCI Insight
spelling doaj.art-ccd29945ae6d4cd399638e7be17fca292022-12-22T02:41:12ZengAmerican Society for Clinical investigationJCI Insight2379-37082021-10-01619Loss of miR-29a/b1 promotes inflammation and fibrosis in acute pancreatitisShatovisha DeyLata M. UdariPrimavera RiveraHernandezJason J. KwonBrandon WillisJeffrey J. EaslerEvan L. FogelStephen PandolJanaiah KotaMicroRNA-29 (miR-29) is a critical regulator of fibroinflammatory processes in human diseases. In this study, we found a decrease in miR-29a in experimental and human chronic pancreatitis, leading us to investigate the regulatory role of the miR-29a/b1 cluster in acute pancreatitis (AP) utilizing a conditional miR-29a/b1–KO mouse model. miR-29a/b1-sufficient (WT) and -deficient (KO) mice were administered supramaximal caerulein to induce AP and characterized at different time points, utilizing an array of IHC and biochemical analyses for AP parameters. In caerulein-induced WT mice, miR-29a remained dramatically downregulated at injury. Despite high-inflammatory milieu, fibrosis, and parenchymal disarray in the WT mice during early AP, the pancreata fully restored during recovery. miR-29a/b1–KO mice showed significantly greater inflammation, lymphocyte infiltration, macrophage polarization, and ECM deposition, continuing until late recovery with persistent parenchymal disorganization. The increased pancreatic fibrosis was accompanied by enhanced TGFβ1 coupled with persistent αSMA+ PSC activation. Additionally, these mice exhibited higher circulating IL-6 and inflammation in lung parenchyma. Together, this collection of studies indicates that depletion of miR-29a/b1 cluster impacts the fibroinflammatory mechanisms of AP, resulting in (a) aggravated pathogenesis and (b) delayed recovery from the disease, suggesting a protective role of the molecule against AP.https://doi.org/10.1172/jci.insight.149539GastroenterologyGenetics
spellingShingle Shatovisha Dey
Lata M. Udari
Primavera RiveraHernandez
Jason J. Kwon
Brandon Willis
Jeffrey J. Easler
Evan L. Fogel
Stephen Pandol
Janaiah Kota
Loss of miR-29a/b1 promotes inflammation and fibrosis in acute pancreatitis
JCI Insight
Gastroenterology
Genetics
title Loss of miR-29a/b1 promotes inflammation and fibrosis in acute pancreatitis
title_full Loss of miR-29a/b1 promotes inflammation and fibrosis in acute pancreatitis
title_fullStr Loss of miR-29a/b1 promotes inflammation and fibrosis in acute pancreatitis
title_full_unstemmed Loss of miR-29a/b1 promotes inflammation and fibrosis in acute pancreatitis
title_short Loss of miR-29a/b1 promotes inflammation and fibrosis in acute pancreatitis
title_sort loss of mir 29a b1 promotes inflammation and fibrosis in acute pancreatitis
topic Gastroenterology
Genetics
url https://doi.org/10.1172/jci.insight.149539
work_keys_str_mv AT shatovishadey lossofmir29ab1promotesinflammationandfibrosisinacutepancreatitis
AT latamudari lossofmir29ab1promotesinflammationandfibrosisinacutepancreatitis
AT primaverariverahernandez lossofmir29ab1promotesinflammationandfibrosisinacutepancreatitis
AT jasonjkwon lossofmir29ab1promotesinflammationandfibrosisinacutepancreatitis
AT brandonwillis lossofmir29ab1promotesinflammationandfibrosisinacutepancreatitis
AT jeffreyjeasler lossofmir29ab1promotesinflammationandfibrosisinacutepancreatitis
AT evanlfogel lossofmir29ab1promotesinflammationandfibrosisinacutepancreatitis
AT stephenpandol lossofmir29ab1promotesinflammationandfibrosisinacutepancreatitis
AT janaiahkota lossofmir29ab1promotesinflammationandfibrosisinacutepancreatitis